David Halverson is the President and CEO of Prolytix. He has over 30 years of experience in the contract research and CDMO industry, including many of the largest CROs. David started his career with Hazleton (Covance), working as a Study Director in the drug metabolism and pharmacokinetics division for 11 years. 

He moved on to PPD, where he spent five years running a GLP/GMP LCMS laboratory and started a program management/technical field sales team. From there, he joined Quintiles and was the Head of North American Business Development (four years) before moving to Cambridge, England, to head up the European Sales Team for Huntingdon Life Sciences. After working at Huntingdon for four years, David worked as the President of Protea for three years, working in the large molecule MS and diagnostic space to help develop an MS imaging-based diagnostic for melanoma. After Protea, David moved to Concept Life Sciences where he was the Head of North American Business Development for three years. Recently, he held the position of President of Scorpius Biomanufacturing for three years, starting the company from the ground up building and staffing a 40,000-square-foot biomanufacturing and large molecule analytical facility. 

After receiving a commission as an officer in the U.S. Army, David honorably served for 13 years as an officer in the ArmorCorps and is a veteran of Desert Shield and Desert Storm, and Operation Joint Guard.